"Sana Biotechnology's HIP-modified Pancreatic Islet Cells"
Digital Health News

Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that Cell Stem Cell has published a paper titled “Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate.” The paper evaluated a transplant of Sana’s engineered allogeneic, hypoimmune (HIP)-modified pancreatic islet cells into […]

Hospital Updates

14-year-old Ethiopian boy undergoes complex kidney transplantation surgery at Aster CMI Hospital

A 14-year-old boy from Ethiopia with stunted growth and bony deformities was given a new lease of life by his father as a kidney donor at Aster CMI Hospital, Bangalore. The child was diagnosed with a condition called posterior urethral valves which causes blockage to the flow of urine. He underwent two surgeries for the […]

Hospital Updates

MGM Healthcare achieves a rare feat of performing combined procedures of Living Donor Liver Transplantation and Coronary Artery Bypass Graft on a patient

MGM Healthcare, Chennai today showcased a successful and a rare and a complex surgery performing a living liver donor transplantation and a beating-heart bypass surgery on a 61-year-old male from Nellore in a single sitting. The dual surgery spanning over 18 hours witnessed 15 doctors from various disciplines achieving the feat with precision. Dr Thiagarajan […]